Park National Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Park National şirketinin toplam varlıkları $9.9B ve toplam özkaynağı $1.2B dır. Toplam mevduat $8.2B ve toplam krediler $7.6B dır. 4.1% Net Faiz Marjı kazanır. Şu anda toplam kredilerin 0.9% i olan kötü krediler için yeterli ödeneği vardır. Nakit ve kısa vadeli yatırımlar $202.4M dir.

Anahtar bilgiler

Varlık/özkaynak oranı

4.1%

Net faiz marjı

Toplam mevduat	US$8.21b
Kredi/mevduat oranı	Uygun
Batık krediler	0.9%
Sorunlu krediler için ayrılan karşılık	Yeterli
Cari oran	Düşük
Nakit ve eşdeğerleri	US$202.36m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Park National Corporation's (NYSEMKT:PRK) CEO Will Probably Have Their Compensation Approved By Shareholders

Apr 20

Are You An Income Investor? Don't Miss Out On Park National Corporation (NYSEMKT:PRK)

Apr 05

If You Like EPS Growth Then Check Out Park National (NYSEMKT:PRK) Before It's Too Late

Mar 08

Be Sure To Check Out Park National Corporation (NYSEMKT:PRK) Before It Goes Ex-Dividend

Feb 13

Results: Park National Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

Jan 29

What Is The Ownership Structure Like For Park National Corporation (NYSEMKT:PRK)?

Jan 25

Read This Before Selling Park National Corporation (NYSEMKT:PRK) Shares

Dec 30

Shareholders Of Park National (NYSEMKT:PRK) Must Be Happy With Their 40% Return

Dec 07

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Varlık Seviyesi: PRK 'nin Varlık/Özsermaye oranı ( 8 x) düşüktür.

Kötü Krediler İçin Ödenek: PRK yeterli kötü krediler için bir ödeneği var ( 122 %).

Düşük Riskli Yükümlülükler: PRK 'un yükümlülüklerinin 95% 'i esas olarak düşük riskli finansman kaynaklarından oluşmaktadır.

Kredi Seviyesi: PRK Kredi/Varlık oranı açısından uygun bir seviyeye sahiptir ( 77% ).

Düşük Riskli Mevduatlar: PRK 'nin Kredi/Mevduat oranı ( 93% ) uygundur.

Kötü Kredilerin Seviyesi: PRK uygun düzeyde kötü krediler içeriyor ( 0.9 %).

Park National Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Third quarter dividend of US$1.56 announced

New major risk - Revenue and earnings growth

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Park National Corporation Declares Special One-Time Dividend, Payable on December 10, 2024

Upcoming dividend of US$1.06 per share

Independent Director recently sold US$2.2m worth of stock

Consensus EPS estimates increase by 11%

Now 21% undervalued

Second quarter dividend of US$1.06 announced

Price target increased by 16% to US$153

Park National Corporation Declares Quarterly Cash Dividend, Payable on September 10, 2024

Investor sentiment improves as stock rises 17%

Park National Corporation Announces Board of Directors Appointments, Effective July 1, 2024

First quarter dividend of US$1.06 announced

First quarter 2024 earnings released: EPS: US$2.18 (vs US$2.08 in 1Q 2023)

Park National Corporation, Annual General Meeting, Apr 22, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target increased by 7.2% to US$129

Upcoming dividend of US$1.06 per share at 3.3% yield

Price target increased by 7.6% to US$128

Fourth quarter dividend of US$1.06 announced

Price target increased by 7.6% to US$120

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target increased by 8.2% to US$119

Upcoming dividend of US$1.05 per share at 4.0% yield

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Park National Corporation Declares Quarterly Cash Dividend, Payable on December 8, 2023

Upcoming dividend of US$1.05 per share at 3.8% yield

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Park National Corporation Reports Net Loan Charge-Offs for the Second Quarter Ended June 30, 2023

Price target decreased by 12% to US$109

Director recently bought US$63k worth of stock

Upcoming dividend of US$1.05 per share at 4.1% yield

CEO & Chairman of the Board exercised options and sold US$123k worth of stock

First quarter 2023 earnings: EPS in line with expectations, revenues disappoint

CEO & Chairman of the Board exercised options and sold US$123k worth of stock

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of US$1.05 per share at 3.3% yield

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Park National Corporation Declares Quarterly Cash Dividend, Payable on March 10, 2023

Now 20% undervalued

Now 20% undervalued

Upcoming dividend of US$1.54 per share

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Park National Corporation Declares Quarterly Cash Dividend, Payable on December 9, 2022

Now 22% undervalued

Upcoming dividend of US$1.04 per share

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Park National Corporation Declares Quarterly Cash Dividend, Payable on September 9, 2022

Upcoming dividend of US$1.04 per share

First quarter 2022 earnings: EPS exceeds analyst expectations

First quarter 2022 earnings: EPS exceeds analyst expectations

Park National Corporation Declares Quarterly Cash Dividend, Payable on June 10, 2022

CEO & Chairman of the Board exercised options and sold US$82k worth of stock

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of US$1.04 per share

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of US$1.23 per share

Third quarter 2021 earnings released: EPS US$2.18 (vs US$1.89 in 3Q 2020)

Price target decreased to US$117

Second quarter 2021 earnings released: EPS US$2.40 (vs US$1.81 in 2Q 2020)

Upcoming dividend of US$1.03 per share

Independent Director has left the company

Consensus forecasts updated

First quarter 2021 earnings released: EPS US$2.63 (vs US$1.37 in 1Q 2020)

Price target increased to US$122

Park National Corporation's (NYSEMKT:PRK) CEO Will Probably Have Their Compensation Approved By Shareholders

Are You An Income Investor? Don't Miss Out On Park National Corporation (NYSEMKT:PRK)

CEO & Chairman of the Board exercised options and sold US$67k worth of stock

If You Like EPS Growth Then Check Out Park National (NYSEMKT:PRK) Before It's Too Late

New 90-day high: US$130

Full year 2020 earnings released: EPS US$7.85 (vs US$6.33 in FY 2019)

Revenue and earnings beat expectations

Be Sure To Check Out Park National Corporation (NYSEMKT:PRK) Before It Goes Ex-Dividend

New 90-day high: US$117